SharonAI shares rally 16% as Nvidia deal overshadows messy Q2 results
SharonAI Holdings shares recovered sharply after an initial post-earnings drop, rising nearly 16% as investors focused on the $4.9 billion NVIDIA partnership. Despite missing Q2 revenue estimates and reporting a wide net loss driven by non-cash items, the stock found support from technical momentum and positive analyst ratings.

*this image is generated using AI for illustrative purposes only.
SharonAI Holdings Inc. (NASDAQ: SHAZ) shares rallied nearly 16% to $65.36 on Wednesday, marking a sharp reversal from the 5.04% decline seen on Friday following its second-quarter earnings release. The stock’s recovery reflects a shift in market sentiment, with traders prioritizing the company’s long-term AI capacity narrative and its strategic collaboration with NVIDIA over the immediate quarterly financial results.
For the quarter ended June 30, SharonAI reported revenue of $1.9 million, a 412% year-over-year increase that fell significantly short of the $7.54 million market estimate. The company recorded a net loss of $430.4 million, widening from the $2.6 million loss in the same period last year. However, this headline loss was primarily driven by non-cash accounting items, including a $400.4 million fair value loss on convertible notes. Excluding these charges, adjusted EBITDA improved to $0.6 million, turning positive from a $1.7 million loss in the prior year period.
Key Financial Metrics
| Metric | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $1.9 million | Not specified | +412% YoY |
| Revenue Estimate | $7.54 million | N/A | Missed |
| Net Loss | $430.4 million | $2.6 million | Widened |
| Adjusted EBITDA | $0.6 million | ($1.7 million) | Turned Positive |
James Manning, co-founder and CEO, stated that the company established commercial, infrastructure, and capital foundations for its next growth phase during the quarter. Management highlighted the $4.9 billion, six-year strategic collaboration with NVIDIA as a key driver for future scale, indicating that revenue is expected to ramp materially from the third quarter of 2026 through 2027.
Technical Setup and Analyst Views
At $65.36, SHAZ is trading 13.5% above its 20-day SMA ($57.57) and 17.2% above its 100-day SMA ($55.77), but remains 4.8% below its 50-day SMA ($68.63). The Relative Strength Index (RSI) sits at 54.25, a neutral reading suggesting the recent rally is not yet overextended. Key resistance is identified at $76.00, while key support stands at $64.50.
The stock carries a Buy rating with an average price forecast of $83.25. Recent analyst actions include:
- Cantor Fitzgerald: Overweight (Lowers Target to $109.00) on August 7
- B. Riley Securities: Initiated with Buy (Target $124.00) on July 9
- Compass Point: Initiated with Buy (Target $50.00) on April 22
What the Numbers Show
The divergence between the stock’s price action and its fundamental results highlights the market’s valuation of future potential versus current execution. While the $430.4 million net loss appears severe, it is distorted by the $400.4 million fair value adjustment on convertible notes, leaving core operations with a positive adjusted EBITDA of $0.6 million. The significant gap between the $1.9 million actual revenue and the $7.54 million estimate underscores challenges in near-term sales scaling, yet the $4.9 billion NVIDIA deal provides a tangible roadmap for material revenue growth starting in late 2026.
How will the material revenue ramp from the NVIDIA collaboration in late 2026 impact SharonAI's cash burn rate and dilution risks from convertible notes?
Given the significant miss on Q2 revenue estimates, what specific operational hurdles must SharonAI overcome to meet market expectations for the third quarter of 2026?
Will the divergence between core adjusted EBITDA positivity and headline net losses continue to drive volatility, or will investors demand stricter adherence to GAAP profitability metrics?






























